As summer winds down and America’s children head back to school, Congress has a major assignment awaiting them when they return from their August recess. Washington lawmakers will have to race to pass various appropriation bills in order to avoid a government shutdown. FOX News Senior Congressional Correspondent Chad Pergram joins to discuss the hurdles that face Congress upon their return, why House Speaker Kevin McCarthy may be reluctant to work with Democrats on the legislation, and how a potential impeachment inquiry into President Biden factors into the negotiation process.
As the United States continues to suffer from drug shortages, many Americans are struggling to fill prescriptions for antibiotics and even some cancer treatments. The reason we’re experiencing this is that many of our country’s pharmaceuticals or their active ingredients are produced overseas. There is a growing effort by some Washington lawmakers to bring production back home and help America become less reliant on countries like China. Eric Edwards, cofounder and CEO of Phlow, a pharmaceutical company based in Richmond, Virginia, joins to discuss the importance of manufacturing active pharmaceutical ingredients domestically and why Congress should push harder for reform.
